VFVeronika S. Frolova

Veronika S. Frolova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Veronika S. Frolova has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Compensatory Serotonin Synthesis and Histone H3 Serotonylation in Preimplantation Embryos Exposed to Maternal Fluoxetine or Monoamine Oxidase Blockade

    by Veronika S. Frolova, Denis A. Nikishin

    Serotonin is a critical morphogen in early development, yet the mechanisms regulating its homeostasis in the preimplantation embryo remain unclear, particularly under conditions of maternal antidepressant exposure. Here, we investigated embryonic serotonergic autonomy using mouse models of pharmacological transport blockade (maternal fluoxetine treatment) and in vitro treatment with the monoamine oxidase inhibitor pargyline. We employed immunofluorescence, RT-qPCR, and live-cell imaging to assess metabolic flux, gene expression, and physiological health. We demonstrate that monoamine oxidase functions as a metabolic firewall, progressively maturing from zygote to blastocyst to degrade excess amines. Paradoxically, maternal serotonin transporter blockade triggered significant intracellular serotonin hyper-accumulation in blastocysts, associated with a trend toward a compensatory upregulation of the biosynthetic gene Ddc. While this serotonin overload did not compromise morphology, mitochondrial function, or pluripotency marker expression, it induced a robust epigenetic response. Excess serotonin promoted elevated H3Q5ser immunoreactivity in both nuclear and cytoplasmic compartments via a transglutaminase-dependent mechanism. These findings reveal that the preimplantation embryo possesses a resilient, autonomous serotonergic system capable of compensatory synthesis. However, environmental fluctuations are chemically recorded via transglutaminase-mediated serotonylation, representing an epigenetic mark that warrants further long-term study within the Developmental Origins of Health and Disease (DOHaD) framework.

  • Open Access

    Fluoxetine Disrupts Ovarian Serotonin Signaling and Oocyte Competence in Mice

    by Nina M. Alyoshina, Maria V. Beketova, Maria D. Tkachenko, Yulia O. Nikishina, Veronika S. Frolova, Lyudmila A. Malchenko, Maria L. Semenova, Maria P. Rubtsova, Denis A. Nikishin

    Background: Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed, yet their direct impact on ovarian function remains poorly understood. While serotonin signaling is known to occur within the ovarian follicle, the specific molecular consequences of its disruption by SSRIs are unclear. This study aimed to elucidate the direct, intra-ovarian mechanisms by which fluoxetine, a common SSRI, affects follicular development and oocyte competence. Methods: We administered fluoxetine (20 mg/kg) or vehicle daily for seven days to both prepubertal and adult female mice to model short-term therapeutic exposure. Results: Fluoxetine treatment successfully blocked peripheral serotonin uptake, reducing serum levels by over 90%. Crucially, this occurred without altering circulating levels of estradiol, FSH, or LH and without disrupting the estrous cycle, indicating a mechanism independent of the central hypothalamic–pituitary–gonadal axis. Instead, we pinpoint a direct ovarian effect: fluoxetine inhibited serotonin transport activity in oocytes and significantly downregulated the expression of the pivotal oocyte-derived growth factor Gdf9. This was accompanied by reduced expression of genes crucial for granulosa cell function (Lhr, Fshr) and steroidogenesis (Cyp19a1). Functionally, these molecular changes manifested as a decline in oocyte quality and a significant reduction in ovulation rates in adult mice. Notably, these detrimental effects were more pronounced in prepubertal mice, indicating a heightened vulnerability during early follicular development. Conclusions: Our findings reveal a direct, intra-ovarian mechanism of fluoxetine-induced disruption. By inhibiting oocyte serotonin transport and downregulating GDF9, fluoxetine impairs critical oocyte–granulosa cell communication, thereby compromising oocyte competence and reducing fertility outcomes. This work identifies follicular development as a critical window of susceptibility to SSRI exposure, holding significant clinical implications for reproductive-aged and adolescent populations.


  • Open Access

    Impact of Chronic Fluoxetine Exposure on Oocyte Development and Reproductive Outcomes in a Mouse Model

    by Maria D. Tkachenko, Nina M. Alyoshina, Yulia O. Nikishina, Veronika S. Frolova, Denis A. Nikishin

    Selective serotonin reuptake inhibitors (SSRIs), like fluoxetine, are increasingly used by women of a reproductive age, raising concerns about their impact on oocyte quality and early embryonic development. This study investigated the effects of chronic fluoxetine exposure on oocyte maturation, ovulation, and embryonic development in a mouse model. Female mice were administered fluoxetine via drinking water, and their reproductive outcomes were compared to those of control mice. Oocyte quantity and quality were assessed following superovulation, including the analysis of spindle morphology, chromatin configuration, and maturation markers. In vitro maturation assays were conducted to evaluate the developmental competence of oocytes exposed to fluoxetine. Finally, the impact of fluoxetine on blastocyst formation, litter size, offspring growth, and ovarian reserve was examined. The results show that fluoxetine treatment reduced the number of ovulated oocytes but did not significantly affect oocyte quality or meiotic spindle formation. Fluoxetine exposure impaired cytoplasmic maturation at the germinal vesicle stage, resulting in a lower proportion of fully mature oocytes and reduced in vitro maturation efficiency. While blastocyst numbers were modestly reduced in fluoxetine-treated mice, litter size and offspring ovarian reserve were unaffected. Unexpectedly, offspring of fluoxetine-treated mothers exhibited increased body weight. These findings suggest that while fluoxetine may impair oocyte developmental competence through disruptions in cytoplasmic maturation, it does not severely compromise overall reproductive outcomes or offspring fertility.


  • Open Access

    Impact of Chronic Fluoxetine Exposure on Oocyte Development and Reproductive Outcomes in a Mouse Model

    by Maria D. Tkachenko, Nina M. Alyoshina, Yulia O. Nikishina, Veronika S. Frolova, Denis A. Nikishin

    Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine are increasingly used by women of reproductive age, raising concerns about their impact on oocyte quality and early embryonic development. This study investigated the effects of chronic fluoxetine exposure on oocyte maturation, ovulation, and embryonic development in a mouse model. Female mice were administered fluoxetine via drinking water, and their reproductive outcomes were compared to those of control mice. Oocyte quantity and quality were assessed following superovulation, including analysis of spindle morphology, chromatin configuration, and maturation markers. In vitro maturation assays were conducted to evaluate the developmental competence of oocytes exposed to fluoxetine. Finally, the impact of fluoxetine on blastocyst formation, litter size, offspring growth, and ovarian reserve was examined. Results showed that fluoxetine treatment reduced the number of ovulated oocytes but did not significantly affect oocyte quality or meiotic spindle formation. Fluoxetine exposure impaired cytoplasmic maturation at the germinal vesicle stage, resulting in a lower proportion of fully mature oocytes and reduced in vitro maturation efficiency. While blastocyst numbers were modestly reduced in fluoxetine-treated mice, litter size and offspring ovarian reserve were unaffected. Unexpectedly, offspring of fluoxetine-treated mothers exhibited increased body weight. These findings suggest that while fluoxetine may impair oocyte developmental competence through disruptions in cytoplasmic maturation, it does not severely compromise overall reproductive outcomes or offspring fertility.


  • Cell proliferation and cell death during whole‐body regeneration in the demosponge Halisarca dujardinii

    by Andrey I. Lavrov, Nikolai P. Melnikov, Fyodor V. Bolshakov, Daniyal M. Saidov, Emilie Le Goff, Kseniia V. Skorentseva, Veronika S. Frolova, Alexander V. Ereskovsky

    Sponges (phylum Porifera) are early‐branching metazoans demonstrating an outstanding example of whole‐body regeneration, cell reaggregation. During the process, single cells form aggregates capable of progressive development and reconstruction of intact sponges. This study provides the first comprehensive analysis of cell proliferation and cell death during cell reaggregation in a marine demosponge, Halisarca dujardinii. Relatively high proliferative activity occurs at the early and late stages of the reaggregation. This proliferation seems to be a consequence of intact tissue turnover rather than a prerequisite for aggregate development. The contribution of cell death is limited to a short period during the aggregate epithelization. Cell reaggregation in demosponges appears to be a morphallactic restorative process relying primarily on cell migration, dedifferentiation, and transdifferentiation.


  • Open Access

    Serotonin Signaling in Mouse Preimplantation Development: Insights from Transcriptomic and Structural-Functional Analyses

    by Veronika S. Frolova, Yulia O. Nikishina, Yuri B. Shmukler, Denis A. Nikishin

    Serotonin (5-HT), a versatile signaling molecule, plays a variety of roles in both neurotransmission and tissue regulation. The influence of serotonin on early development was first studied in marine invertebrate embryos and has since been documented in a variety of vertebrate species, including mammals. The present study investigates the expression and functional activity of serotonin components in mouse embryos, focusing on key receptors and transporters. Transcriptomic analyses revealed that mRNA transcripts related to serotonin show marked expression during the oogenesis and preimplantation stages. The results of the immunohistochemical studies show the presence of serotonin, the vesicular monoamine transporter VMAT2, and several membrane receptors (5-HT1B, 5-HT1D, 5-HT2B, 5-HT7) in the early stages of development. A functional analysis performed with the VMAT inhibitor reserpine revealed the crucial role of vesicular transport in the maintenance of serotonin signaling. The findings presented here support the hypothesis that serotonin plays a significant role in oocyte maturation and embryonic development, as well as in interblastomere interactions.


  • Spatial Organization of the Components of the Serotonergic System in the Early Mouse Development

    by V. S. Frolova, A. D. Ivanova, M. S. Konorova, Yu. B. Shmukler, D. A. Nikishin

    Serotonin is a regulator of early embryonic development and has a complete functional system in preimplantation mammalian embryos. In the present work, the spatial distribution of serotonin, the vesicular monoamine transporter VMAT2, and the 5-HT1D and 5-HT2A receptors at different stages of early embryonic development was described. Serotonin, the VMAT2 transporter, and the 5-HT1D receptor are visualized in the cortical compartment of cells, whereas the 5-HT2A receptor has a more even distribution throughout the cytoplasm. The comparison showed that there were no statistically significant differences between the immunoreactive particle sizes of serotonin and the VMAT2 transporter, suggesting the presence of vesicles in which serotonin accumulates with the involvement of VMAT2 for further intercellular signal transduction. Moreover, the patterns of immunoreactivity of the two serotonin receptors, 5-HT1D and 5-HT2A, differ markedly, which may indicate that they simultaneously serve different functions in early embryogenesis.


  • Spatial Organization of the Components of the Serotonergic System in the Early Mouse Development

    by V. S. Frolova, A. D. Ivanova, M. S. Konorova, Yu. B. Shmukler, D. A. Nikishin

    Serotonin is a regulator of early embryonic development and has a fully functional system in preimplantation mammalian embryos. In this work, we described the spatial distribution of serotonin, the vesicular monoamine transporter VMAT2, and the serotonin receptors 5-HT1D and 5-HT2A at different stages of early mouse embryonic development. Serotonin, the VMAT2 transporter, and the 5-HT1D receptor are visualized in the cortical compartment of cells, whereas the 5-HT2A receptor has a more uniform distribution throughout the cytoplasm. Comparison of the sizes of the immunoreactive particles showed that there are no statistically significant differences between serotonin and the VMAT2 transporter, which may indicate the presence of specific vesicles containing serotonin. In addition, the two serotonin receptors, 5-HT1D and 5-HT2A, showed a markedly different pattern of immunoreactivity, which may indicate that they simultaneously serve different functions in early embryogenesis.